Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rochelle Hanley currently holds 160,836 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rochelle Hanley has been a net neutral trader of VKTX stock. They have purchased $0 and sold $0 worth of shares.
Rochelle Hanley's most recent insider trade was on May 4, 2016, when they sold 10,595 shares at $1.31 per share.
Rochelle Hanley serves as Executive at Viking Therapeutics, Inc. (VKTX). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Rochelle Hanley holds the position of Executive at Viking Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Rochelle Hanley has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Rochelle Hanley was on May 4, 2015, when they sold $69.4K worth of VKTX shares. This transaction involved 7,308 shares at $9.49 per share.
Rochelle Hanley currently owns 160,836 shares of Viking Therapeutics, Inc. (VKTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rochelle Hanley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rochelle Hanley has 4 Form 4 filings on record as an insider at Viking Therapeutics, Inc..
Set alerts for Rochelle Hanley and 40,000+ other insiders.